BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10823524)

  • 21. Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
    Singh AD; Parmar S; Patel K; Shah S; Shore T; Gergis U; Mayer S; Phillips A; Hsu JM; Niesvizky R; Mark TM; Pearse R; Rossi A; van Besien K
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):288-293. PubMed ID: 29061534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
    Gathwala G; Walia M; Bala H; Singh S
    J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies.
    Mac Manus MP; McCormick D; Trimble A; Abram WP
    Eur J Cancer; 1995; 31A(3):302-7. PubMed ID: 7540401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
    MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
    Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood neutrophil increment after a single injection of rhG-CSF or rhGM-CSF correlates with marrow cellularity and may predict the grade of neutropenia after chemotherapy.
    Hansen PB; Johnsen HE; Ralfkiaer E; Hansen NE
    Br J Haematol; 1993 Aug; 84(4):581-5. PubMed ID: 7692936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet-lymphocyte Ratio After Granulocyte Colony Stimulating Factor Administration: an Early Prognostic Marker in Septic Shock Patients With Chemotherapy-Induced Febrile Neutropenia.
    Kim YJ; Kang J; Ryoo SM; Ahn S; Huh JW; Kim WY
    Shock; 2019 Aug; 52(2):160-165. PubMed ID: 30148761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) for the treatment of neonates in presumed sepsis with neutropenia.
    Khan TH; Shahidullah M; Mannan MA; Nahar N
    Mymensingh Med J; 2012 Jul; 21(3):469-74. PubMed ID: 22828545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.
    Bedford Russell AR; Emmerson AJ; Wilkinson N; Chant T; Sweet DG; Halliday HL; Holland B; Davies EG
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F172-6. PubMed ID: 11320043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia.
    Kearns CM; Wang WC; Stute N; Ihle JN; Evans WE
    J Pediatr; 1993 Sep; 123(3):471-9. PubMed ID: 7689097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
    Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
    Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
    Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.
    Meisenberg BR; Davis TA; Melaragno AJ; Stead R; Monroy RL
    Blood; 1992 May; 79(9):2267-72. PubMed ID: 1373969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte colony-stimulating factor (G-CSF) stiffens leukocytes but attenuates inflammatory response without lung injury in septic patients.
    Tanaka H; Nishino M; Nakamori Y; Ogura H; Ishikawa K; Shimazu T; Sugimoto H
    J Trauma; 2001 Dec; 51(6):1110-6. PubMed ID: 11740262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.